Clark Capital Management Group, Inc. Pfizer Inc Transaction History

Clark Capital Management Group, Inc.

$13.3 Billion
Q2 2024

A detailed history of Clark Capital Management Group, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Clark Capital Management Group, Inc. holds 31,779 shares of PFE stock, worth $849,134. This represents 0.01% of its overall portfolio holdings.

Number of Shares

31,779

Previous 16,254 95.51%

Holding current value

$849,134

Previous $451,000 97.12%

% of portfolio

0.01%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $392,161 - $459,540	15,525 Added 95.51%	31,779 $889,000
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $195,598 - $224,610	-7,555 Reduced 31.73%	16,254 $451,000
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $17.9 Million - $23.3 Million	-686,282 Reduced 96.65%	23,809 $685,000
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $425,770 - $497,682	13,268 Added 1.9%	710,091 $23.6 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $728,251 - $842,569	20,162 Added 2.98%	696,823 $25.6 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $456,333 - $594,078	11,585 Added 1.74%	676,661 $27.6 Million
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $1.08 Million - $1.41 Million	25,784 Added 4.03%	665,076 $34.1 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $13.2 Million - $16.1 Million	-302,292 Reduced 32.1%	639,292 $28 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $5.08 Million - $6.03 Million	109,245 Added 13.13%	941,584 $49.4 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $11.6 Million - $14.4 Million	253,926 Added 43.9%	832,339 $43.1 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $23.5 Million - $34.8 Million	568,479 Added 5722.56%	578,413 $34.2 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $16,759 - $21,529	427 Added 4.49%	9,934 $427,000
Q2 2021 Aug 02, 2021	BUY	$35.91 - $40.68 $53,290 - $60,369	1,484 Added 18.5%	9,507 $372,000
Q1 2021 May 17, 2021	SELL	$33.49 - $37.77 $18.8 Million - $21.2 Million	-562,035 Reduced 98.59%	8,023 $291,000
Q4 2020 Jan 26, 2021	SELL	$33.47 - $42.56 $295,707 - $376,017	-8,835 Reduced 1.53%	570,058 $21 Million
Q3 2020 Nov 12, 2020	SELL	$31.75 - $37.25 $22,288 - $26,149	-702 Reduced 0.12%	578,893 $21.2 Million
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $124,154 - $150,617	4,122 Added 0.72%	579,595 $19 Million
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $215,510 - $307,917	-7,973 Reduced 1.37%	575,473 $18.8 Million
Q4 2019 Jan 27, 2020	BUY	$32.92 - $37.36 $210,720 - $239,141	6,401 Added 1.11%	583,446 $22.9 Million
Q3 2019 Nov 06, 2019	SELL	$32.49 - $42.13 $20.7 Million - $26.9 Million	-637,416 Reduced 52.49%	577,045 $20.7 Million
Q2 2019 Jul 12, 2019	BUY	$36.98 - $41.52 $13.3 Million - $14.9 Million	358,928 Added 41.95%	1,214,461 $52.6 Million
Q1 2019 May 08, 2019	SELL	$37.5 - $41.2 $19.1 Million - $20.9 Million	-508,242 Reduced 37.27%	855,533 $36.3 Million
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $2.21 Million - $2.52 Million	-57,474 Reduced 4.04%	1,363,775 $59.5 Million
Q3 2018 May 08, 2019	SELL	$34.47 - $41.81 $19,820 - $24,040	-575 Reduced 0.04%	1,421,249 $62.6 Million
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $48.6 Million - $59 Million	1,411,163 Added 13236.69%	1,421,824 $62.7 Million
Q2 2018 May 08, 2019	SELL	$32.98 - $35.16 $73,941 - $78,828	-2,242 Reduced 17.38%	10,661 $387,000
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $9,795 - $10,442	-297 Reduced 2.25%	12,903 $468,000
Q1 2018 May 08, 2019	SELL	$31.91 - $37.02 $73,680 - $85,479	-2,309 Reduced 14.89%	13,200 $468,000
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $52,938 - $61,416	1,659 Added 11.98%	15,509 $550,000
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $100,578 - $106,716	3,024 Added 27.93%	13,850 $502,000
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $335,606 - $369,707	10,826	10,826 $386,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.73B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clark Capital Management Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Clark Capital Management Group, Inc. with notifications on news.

Account

Clark Capital Management Group, Inc. Pfizer Inc Transaction History